Topical Absorbable Hemostats Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Topical Absorbable Hemostats Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

Summary

GlobalData's Medical Devices sector report, “Topical Absorbable Hemostats Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update provides comprehensive information about the Topical Absorbable Hemostats pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Topical absorbable hemostats are agents used to promote and accelerate hemostasis to control bleeding in cases where application of pressure, ligature and other conventional methods is ineffective.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Topical Absorbable Hemostats under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Topical Absorbable Hemostats and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Topical Absorbable Hemostats under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


  • About GlobalData
  • Introduction
    • Topical Absorbable Hemostats Overview
  • Products under Development
    • Topical Absorbable Hemostats - Pipeline Products by Stage of Development
      • Table Figure 1: Topical Absorbable Hemostats - Pipeline Products by Stage of Development
      • Table Topical Absorbable Hemostats - Pipeline Products by Stage of Development
    • Topical Absorbable Hemostats - Pipeline Products by Segment
      • Table Figure 2: Topical Absorbable Hemostats - Pipeline Products by Segment
      • Table Topical Absorbable Hemostats - Pipeline Products by Segment
    • Topical Absorbable Hemostats - Pipeline Products by Territory
      • Table Figure 3: Topical Absorbable Hemostats - Pipeline Products by Territory
      • Table Topical Absorbable Hemostats - Pipeline Products by Territory
    • Topical Absorbable Hemostats - Pipeline Products by Regulatory Path
      • Table Figure 4: Topical Absorbable Hemostats - Pipeline Products by Regulatory Path
      • Table Topical Absorbable Hemostats - Pipeline Products by Regulatory Path
    • Topical Absorbable Hemostats - Pipeline Products by Estimated Approval Date
      • Table Figure 5: Topical Absorbable Hemostats - Pipeline Products by Estimated Approval Date
      • Table Topical Absorbable Hemostats - Pipeline Products by Estimated Approval Date
    • Topical Absorbable Hemostats - Ongoing Clinical Trials
      • Table Figure 6: Topical Absorbable Hemostats - Ongoing Clinical Trials
      • Table Topical Absorbable Hemostats - Ongoing Clinical Trials
  • Topical Absorbable Hemostats - Pipeline Products under Development by Companies
    • Topical Absorbable Hemostats Companies - Pipeline Products by Stage of Development
      • Table Topical Absorbable Hemostats Companies - Pipeline Products by Stage of Development
    • Topical Absorbable Hemostats – Companies Pipeline Products by Stage of Development
      • Table Topical Absorbable Hemostats – Companies Pipeline Products by Stage of Development
  • Topical Absorbable Hemostats Companies and Product Overview
    • 3-D Matrix Ltd Company Overview
      • 3-D Matrix Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table 3-D Matrix Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table PuraStat - Product Status
        • Table PuraStat - Product Description
        • Table TDM-623 - Product Status
        • Table TDM-623 - Product Description
        • Table 3-D Matrix Ltd - Ongoing Clinical Trials Overview
        • Table PuraStat - A Multi-center, Single Arm Post-market Clinical Study to Confirm Safety and Performance of Purastat Absorbable Haemostatic Material for the Management of Bleeding after Open Liver Resection
        • Table PuraStat - A Multicenter Prospective Observational Study to Evaluate the Utilization, Effectiveness and Safety of Purastat in the Management of Gastrointestinal Bleeding
        • Table PuraStat - A Study to Evaluate the Effectiveness of Purastat in the Prevention of Delayed Bleeding after EMR of Non-ampullary Duodenal Lesions
        • Table PuraStat - Efficacy of PuraStat for the Prevention of Delayed Bleeding after Endoscopic Resection of Colorectal Lesions
        • Table PuraStat - Endoscopically-delivered Purastat for the Treatment of Haemorrhagic Radiation Proctopathy: A Randomised Feasibility Study
        • Table PuraStat - The Hemostatic Potential of TDM-621 on Ascending Aortic Surgery
    • Acro Biomedical Co Ltd Company Overview
      • Acro Biomedical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Acro Biomedical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table ACROHCM - Product Status
        • Table ACROHCM - Product Description
    • Advanced Biotech Products Pvt Ltd Company Overview
      • Advanced Biotech Products Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Advanced Biotech Products Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hemocoll - Product Status
        • Table Hemocoll - Product Description
    • Angiotech Pharmaceuticals Inc Company Overview
      • Angiotech Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Angiotech Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hemaseel Thrombin Haemostatic Agent - Product Status
        • Table Hemaseel Thrombin Haemostatic Agent - Product Description
    • Anika Therapeutics Inc Company Overview
      • Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hemostatic Patch - Product Status
        • Table Hemostatic Patch - Product Description
    • APRUS Bio-Medical Innovations Pvt Ltd Company Overview
      • APRUS Bio-Medical Innovations Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table APRUS Bio-Medical Innovations Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Deep Wound Hemostat - Product Status
        • Table Deep Wound Hemostat - Product Description
    • Arch Therapeutics Inc Company Overview
      • Arch Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Arch Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table AC5 - Burns - Product Status
        • Table AC5 - Burns - Product Description
        • Table AC5 - Diabetic Ulcers - Product Status
        • Table AC5 - Diabetic Ulcers - Product Description
        • Table AC5 - Pressure Ulcers - Product Status
        • Table AC5 - Pressure Ulcers - Product Description
        • Table AC5 - V - Product Status
        • Table AC5 - V - Product Description
        • Table AC5 Surgical Hemostatic Device - Product Status
        • Table AC5 Surgical Hemostatic Device - Product Description
    • Baxter Healthcare Corp Company Overview
      • Baxter Healthcare Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Baxter Healthcare Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Celstat Topical Hemostatic Dressing - Product Status
        • Table Celstat Topical Hemostatic Dressing - Product Description
        • Table PerClot - Product Status
        • Table PerClot - Product Description
    • Beth Israel Deaconess Medical Center Company Overview
      • Beth Israel Deaconess Medical Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table Beth Israel Deaconess Medical Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table Portable Wound Hemostasis System - Product Status
        • Table Portable Wound Hemostasis System - Product Description
    • Biomedica Management Corp Company Overview
      • Biomedica Management Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biomedica Management Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table ClotFoam - Product Status
        • Table ClotFoam - Product Description
        • Table ClotGel - Product Status
        • Table ClotGel - Product Description
        • Table ClotSpray - Product Status
        • Table ClotSpray - Product Description
    • Biom'Up SAS Company Overview
      • Biom'Up SAS Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biom'Up SAS Pipeline Products & Ongoing Clinical Trials Overview
        • Table HEMOSNOW - Product Status
        • Table HEMOSNOW - Product Description
    • Cellphire Inc Company Overview
      • Cellphire Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cellphire Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Thromboderm - Product Status
        • Table Thromboderm - Product Description
        • Table Thrombosomes - Product Status
        • Table Thrombosomes - Product Description
        • Table Cellphire Inc - Ongoing Clinical Trials Overview
        • Table Thrombosomes - A Phase I, Multi-center, Open-label, Dose Escalation Study of Thrombosomes in Bleeding Thrombocytopenic Patients in Three Cohorts
    • Ceramicos Para Aplicacoes Medicas SA Company Overview
      • Ceramicos Para Aplicacoes Medicas SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ceramicos Para Aplicacoes Medicas SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table HemoKi - Product Status
        • Table HemoKi - Product Description
    • Columbia University Company Overview
      • Columbia University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Columbia University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hemostatic Wound Dressing - Product Status
        • Table Hemostatic Wound Dressing - Product Description
    • Covalent Medical, Inc. (Inactive) Company Overview
      • Covalent Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Covalent Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table CovaSTAT - Product Status
        • Table CovaSTAT - Product Description
    • Covalon Technologies Ltd Company Overview
      • Covalon Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Covalon Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table ColActive THP - Product Status
        • Table ColActive THP - Product Description
        • Table CovaStat BioActive Absorbable Hemostatic Sponge - Product Status
        • Table CovaStat BioActive Absorbable Hemostatic Sponge - Product Description
    • CR Bard Inc Company Overview
      • CR Bard Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table CR Bard Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Absorbable Hemostat - Product Status
        • Table Absorbable Hemostat - Product Description
        • Table New Hemostat 1 - Product Status
        • Table New Hemostat 1 - Product Description
        • Table New Hemostat 2 - Product Status
        • Table New Hemostat 2 - Product Description
    • Cresilon Inc Company Overview
      • Cresilon Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cresilon Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hemostatic Gel - Product Status(Cresilon Inc)
        • Table Hemostatic Gel - Product Description(Cresilon Inc)
        • Table TRAUMAGEL - Product Status
        • Table TRAUMAGEL - Product Description
    • Endomedix Incorporated Company Overview
      • Endomedix Incorporated Pipeline Products & Ongoing Clinical Trials Overview
        • Table Endomedix Incorporated Pipeline Products & Ongoing Clinical Trials Overview
        • Table Surgical Hemostat - Intracranial Surgery - Product Status
        • Table Surgical Hemostat - Intracranial Surgery - Product Description
        • Table Topical Hemostat - Product Status
        • Table Topical Hemostat - Product Description
    • Entegrion Inc Company Overview
      • Entegrion Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Entegrion Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Stasix - Product Status
        • Table Stasix - Product Description
    • Ethicon US LLC Company Overview
      • Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ethicon US LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Next Gen Hemostat Kit - Product Status
        • Table Next Gen Hemostat Kit - Product Description
        • Table SURGIFLO - Sterile Field Preparation - Product Status
        • Table SURGIFLO - Sterile Field Preparation - Product Description
    • ETX Pharma Inc Company Overview
      • ETX Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ETX Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ETX-302 - Product Status
        • Table ETX-302 - Product Description
    • Gamma Diagnostics Inc Company Overview
      • Gamma Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Gamma Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table GammaTF - Product Status
        • Table GammaTF - Product Description
    • GATT Technologies BV Company Overview
      • GATT Technologies BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table GATT Technologies BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table GATT-Patch - Product Status
        • Table GATT-Patch - Product Description
        • Table GATT-Powder - Product Status
        • Table GATT-Powder - Product Description
    • Haemostatix Ltd Company Overview
      • Haemostatix Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Haemostatix Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Haemoplax - Product Status
        • Table Haemoplax - Product Description
        • Table PeproStat - Product Status
        • Table PeproStat - Product Description
    • Hemostasis LLC Company Overview
      • Hemostasis LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hemostasis LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table ACCEL Absorbable Hemostat - Product Status
        • Table ACCEL Absorbable Hemostat - Product Description
        • Table ENT Hemostat - Product Status
        • Table ENT Hemostat - Product Description
        • Table Hemostatic Gel - Product Status(Hemostasis LLC)
        • Table Hemostatic Gel - Product Description(Hemostasis LLC)
        • Table Hemostasis LLC - Ongoing Clinical Trials Overview
        • Table ACCEL Absorbable Hemostat - ACCEL Absorbable Hemostat Powder Clinical Trial
    • HLL Lifecare Ltd Company Overview
      • HLL Lifecare Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table HLL Lifecare Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hinstat Ext - Product Status
        • Table Hinstat Ext - Product Description
    • Ichor Sciences LLC Company Overview
      • Ichor Sciences LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ichor Sciences LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Statbond ENT - Product Status
        • Table Statbond ENT - Product Description
    • Keratin Biosciences Inc Company Overview
      • Keratin Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Keratin Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Keratin-Based Hemostat - Product Status
        • Table Keratin-Based Hemostat - Product Description
    • Leader Biomedical Europe BV Company Overview
      • Leader Biomedical Europe BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Leader Biomedical Europe BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Collagen-Based Haemostatic Device - Product Status
        • Table Collagen-Based Haemostatic Device - Product Description
    • Medcura Inc Company Overview
      • Medcura Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Medcura Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hemogrip Foam - Product Status
        • Table Hemogrip Foam - Product Description
        • Table LifeFoam - Product Status
        • Table LifeFoam - Product Description
        • Table LifeGel - Product Status
        • Table LifeGel - Product Description
    • Protege Biomedical LLC Company Overview
      • Protege Biomedical LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Protege Biomedical LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ionic Hemostatic Mineral Bandage - Emergency Trauma - Product Status
        • Table Ionic Hemostatic Mineral Bandage - Emergency Trauma - Product Description
    • Resorba GmbH Company Overview
      • Resorba GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Resorba GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Antibiotic Hemostat - Product Status
        • Table Antibiotic Hemostat - Product Description
        • Table RESORBA - Cardiac Surgery - Product Status
        • Table RESORBA - Cardiac Surgery - Product Description
    • Rice University Company Overview
      • Rice University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Rice University Pipeline Products & Ongoing Clinical Trials Overview
        • Table KOD Hydrogel Hemostat - Product Status
        • Table KOD Hydrogel Hemostat - Product Description
    • Sanofi Biosurgery Inc Company Overview
      • Sanofi Biosurgery Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sanofi Biosurgery Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table LeSeal - Product Status
        • Table LeSeal - Product Description
        • Table Lumagel - Product Status
        • Table Lumagel - Product Description
    • Sea Run Holdings Inc Company Overview
      • Sea Run Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sea Run Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table SEA-STAT - Product Status
        • Table SEA-STAT - Product Description
    • St Teresa Medical Inc Company Overview
      • St Teresa Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table St Teresa Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Surgiclot - Product Status
        • Table Surgiclot - Product Description
        • Table WRAPCLOT - Product Status
        • Table WRAPCLOT - Product Description
    • STB Lifesaving Technologies Company Overview
      • STB Lifesaving Technologies Pipeline Products & Ongoing Clinical Trials Overview
        • Table STB Lifesaving Technologies Pipeline Products & Ongoing Clinical Trials Overview
        • Table FAST Dressing - Product Status
        • Table FAST Dressing - Product Description
    • Tectum Company Overview
      • Tectum Pipeline Products & Ongoing Clinical Trials Overview
        • Table Tectum Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hemostatic Gel - Product Status(Tectum)
        • Table Hemostatic Gel - Product Description(Tectum)
        • Table Wound Dressing With Hemostat - Product Status
        • Table Wound Dressing With Hemostat - Product Description
    • The Medicines Co Company Overview
      • The Medicines Co Pipeline Products & Ongoing Clinical Trials Overview
        • Table The Medicines Co Pipeline Products & Ongoing Clinical Trials Overview
        • Table Fibropad Patch - Product Status
        • Table Fibropad Patch - Product Description
    • Therus Corporation Company Overview
      • Therus Corporation Pipeline Products & Ongoing Clinical Trials Overview
        • Table Therus Corporation Pipeline Products & Ongoing Clinical Trials Overview
        • Table Therus Acoustic Hemostasis System - Product Status
        • Table Therus Acoustic Hemostasis System - Product Description
    • Thrombotargets Corp Company Overview
      • Thrombotargets Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Thrombotargets Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Next Generation TT-173 - Product Status
        • Table Next Generation TT-173 - Product Description
        • Table TT-173 - Product Status
        • Table TT-173 - Product Description
        • Table Thrombotargets Corp - Ongoing Clinical Trials Overview
        • Table TT-173 - A Phase II/III, Randomized, Controlled, Single Blind Study to Evaluate the Haemostatic Efficacy and Safety of Topically Applied TT-173 in Patients Undergoing Knee Arthroplasty
    • United Health Products, Inc. Company Overview
      • United Health Products, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table United Health Products, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table HemoStyp - Surgical Wounds - Product Status
        • Table HemoStyp - Surgical Wounds - Product Description
        • Table HemoStyp - Trauma - Product Status
        • Table HemoStyp - Trauma - Product Description
        • Table HemoStyp External Procedure Gauze - Product Status
        • Table HemoStyp External Procedure Gauze - Product Description
        • Table HemoStyp hydrocolloid - Product Status
        • Table HemoStyp hydrocolloid - Product Description
        • Table HemoStyp Internal Procedure Gauze - Product Status
        • Table HemoStyp Internal Procedure Gauze - Product Description
        • Table Hemostyp Internal Procedure Gauze - Orthopedic - Product Status
        • Table Hemostyp Internal Procedure Gauze - Orthopedic - Product Description
        • Table HemoStyp Trauma Gauze - Product Status
        • Table HemoStyp Trauma Gauze - Product Description
    • University of Grenoble Alpes Company Overview
      • University of Grenoble Alpes Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Grenoble Alpes Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bleeding Controlling Device - Product Status
        • Table Bleeding Controlling Device - Product Description
    • Virginia Commonwealth University Company Overview
      • Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview
        • Table BioHemostat - Product Status
        • Table BioHemostat - Product Description
    • Xcede Technologies Inc Company Overview
      • Xcede Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Xcede Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Xcede - Femoral Artery - Product Status
        • Table Xcede - Femoral Artery - Product Description
        • Table Xcede - Laparoscopic Surgery - Product Status
        • Table Xcede - Laparoscopic Surgery - Product Description
        • Table Xcede - Lung Sealing - Product Status
        • Table Xcede - Lung Sealing - Product Description
        • Table Xcede - Vascular Surgery - Product Status
        • Table Xcede - Vascular Surgery - Product Description
        • Table Xcede Patch - Liver Resection - Product Status
        • Table Xcede Patch - Liver Resection - Product Description
    • Z-Medica LLC Company Overview
      • Z-Medica LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Z-Medica LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table QuikClot Control+ - Class I and Class II Bleeding - Product Status
        • Table QuikClot Control+ - Class I and Class II Bleeding - Product Description
        • Table Z-Medica LLC - Ongoing Clinical Trials Overview
        • Table QuikClot Control+ - Class I and Class II Bleeding - A Cardiac Investigational Device Exemption Study to Evaluate the Efficacy of QuikClot Control+ for Class I and II Bleeding in Patients Undergoing Cardiac Surgery
  • Topical Absorbable Hemostats- Recent Developments
    • Jun 10, 2022: Anika to Participate in the Sidoti Small Cap Virtual Investor Conference
    • Jun 08, 2022: Baxter to Host Second-Quarter 2022 Financial Results Conference Call for Investors
    • May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results
    • May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase
    • May 25, 2022: Baxter Highlights Business Strategies and Innovation at 2022 Investor Conference
    • May 16, 2022: Analysts Anticipate Artivion to Announce $0.09 Earnings Per Share
    • May 13, 2022: Cadila Pharma appoints Jawed Zia as CEO
    • May 12, 2022: Johnson & Johnson to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference
    • May 11, 2022: Johnson & Johnson Appoints Thibaut Mongon as CEO Designate of Planned New Consumer Health Company
    • May 10, 2022: Johnson & Johnson MedTech Adds New CFO to the Mix
    • May 10, 2022: Baxter to Host 2022 Investor Conference
    • May 09, 2022: Anika to Participate in the UBS Global Healthcare Conference 2022
    • May 05, 2022: Anika Reports First Quarter Fiscal 2022 Financial Results
    • May 03, 2022: Sanofi: Annual General Meeting of May 3, 2022
    • May 02, 2022: Johnson & Johnson to Participate in the Bernstein 38th Annual Strategic Decisions Conference
    • Apr 27, 2022: Merit Medical Reports Results for Quarter Ended March 31, 2022
    • Apr 21, 2022: Artivion Announces Release Date and Teleconference Call Details for First Quarter 2022 Financial Results
    • Apr 21, 2022: Merit Medical Announces Chief Operating Officer Transition
    • Apr 20, 2022: Johnson & Johnson to Participate in the UBS Global Healthcare Conference
    • Apr 19, 2022: Johnson & Johnson Reports Q1 2022 Results
    • Apr 07, 2022: Anika to Issue First Quarter 2022 Financial Results on Thursday, May 5, 2022
    • Apr 07, 2022: Johnson & Johnson to Participate in the BofA Securities 2022 Healthcare Conference
    • Apr 04, 2022: Anika to Participate in the 21st Annual Needham Virtual Healthcare Conference
    • Mar 15, 2022: Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
    • Mar 10, 2022: Anika to Participate in the Canaccord Genuity Musculoskeletal Conference
    • Mar 09, 2022: Artivion to Host Investor & Analyst Day on March 23, 2022
    • Mar 08, 2022: Anika Reports Fourth Quarter and Year-End 2021 Financial Results
    • Feb 22, 2022: Sanara MedTech Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2021
    • Feb 15, 2022: Johnson & Johnson Names Darius Adamczyk, Chairman and Chief Executive Officer of Honeywell, to its Board of Directors
    • Feb 10, 2022: Baxter to Present at Citi's 2022 Virtual Healthcare Conference
    • Feb 09, 2022: Johnson & Johnson to Participate in the Raymond James 43rd Annual Institutional Investors Conference
    • Feb 08, 2022: Anika to Issue Fourth Quarter and Year-End 2021 Financial Results on Tuesday, March 8, 2022
    • Feb 07, 2022: Johnson & Johnson to Participate in the Cowen 42nd Annual Health Care Virtual Conference
    • Jan 27, 2022: Johnson & Johnson to Participate in Citi's 2022 Virtual Healthcare Conference
    • Jan 25, 2022: Johnson & Johnson Reports Q4 and Full-Year 2021 Results
    • Jan 06, 2022: Baxter to Host Fourth-Quarter 2021 Financial Results Conference Call for Investors
    • Jan 04, 2022: Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference
    • Jan 04, 2022: Arch Therapeutics Announces Appointment of Guy Fish to the Board
    • Dec 22, 2021: Sanara MedTech Announces the Retirement of J. Michael Carmena and Appointment of Eric Tanzberger to its Board of Directors
    • Dec 22, 2021: United Health Products provides regulatory status update
    • Dec 15, 2021: Sanara MedTech Announces the Appointment of Roszell Mack III to its Board of Directors
    • Dec 13, 2021: Covalon Announces Strong Year End and Fourth Quarter Results for Fiscal 2021
    • Dec 10, 2021: Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results
    • Dec 08, 2021: Johnson & Johnson to Participate in the 40th Annual J.P. Morgan Healthcare Conference
    • Dec 08, 2021: Dr Jens von Lackum appointed to the Management Board of B. Braun SE
    • Nov 18, 2021: Anika to Participate in Upcoming Investor Conferences
    • Nov 08, 2021: IntelliCentrics and EUCARE Announce Strategic Partnership Supporting Delivery of Taiwan's High-Quality, Integrated Medical Services to the World
    • Nov 04, 2021: Anika Reports Third Quarter 2021 Financial Results
    • Nov 02, 2021: Baxter to Present at Evercore ISI 4th Annual HealthCONx Conference
    • Nov 01, 2021: Anika Appoints Sheryl Conley to Board of Directors
    • Oct 28, 2021: Sanofi announces strong Q3 performance drives guidance upgrade to around 14% business EPS growth at CER
    • Oct 28, 2021: Merit Medical Reports Results For Quarter Ended September 30, 2021
    • Oct 18, 2021: Anika to Issue Third Quarter 2021 Financial Results on Thursday, November 4, 2021
    • Oct 13, 2021: Baxter to Present at Credit Suisse 30th Annual Virtual Healthcare Conference
    • Oct 12, 2021: Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson To Retire, Effective December 31, 2021
    • Oct 12, 2021: Johnson & Johnson Announces Jessica Moore as Vice President of Investor Relations
    • Oct 11, 2021: Johnson & Johnson to Participate in the Credit Suisse 30th Annual Healthcare Conference
    • Oct 05, 2021: Merit Medical Systems to Announce Third Quarter Results on October 28, 2021
    • Sep 27, 2021: Baxter to Host Third-Quarter 2021 Financial Results Conference Call for Investors
    • Sep 22, 2021: Anthony Semedo Joins CryoLife Board of Directors
    • Sep 16, 2021: Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
    • Sep 09, 2021: Merit Medical Systems to Announce First Quarter Results on April 29, 2021
    • Sep 07, 2021: Anika to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference
    • Aug 30, 2021: Covalon Announces Fiscal 2021 Q3 Results
    • Aug 19, 2021: Alex Gorsky to Serve as Executive Chairman and Transition Role of Chief Executive Officer of Johnson & Johnson to Joaquin Duato, Effective January 3, 2022
    • Aug 12, 2021: Johnson & Johnson to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference
    • Aug 09, 2021: Johnson & Johnson to Participate in Barclays Global Consumer Staples Virtual Conference
    • Jul 29, 2021: Baxter Reports Second-Quarter 2021 Results
    • Jul 29, 2021: Sanofi announces half-year financial report for period ending June 30, 2021
    • Jul 29, 2021: Baxter to Present at UBS Genomics 2.0 and MedTech Innovations Summit
    • Jul 29, 2021: CryoLife Reports Second Quarter 2021 Financial Results
    • Jul 27, 2021: Johnson & Johnson to Participate in the Virtual Wells Fargo Healthcare Conference
    • Jul 27, 2021: Stryker reports second quarter 2021 operating results
    • Jul 21, 2021: Johnson & Johnson Reports 2021 Second-Quarter Results
    • Jul 19, 2021: Anika to Issue Second Quarter 2021 Financial Results on Thursday, August 5, 2021
    • Jul 15, 2021: CryoLife Announces Release Date and Teleconference Call Details for Second Quarter 2021 Financial Results
    • Jul 09, 2021: Merit Medical Systems to Announce Second Quarter Results on July 29, 2021
    • Jul 07, 2021: Advanced Medical Solutions Group: Half year trading update
    • Jun 30, 2021: B. Braun Announces Jennifer Prioleau as New Chief Legal Officer and Chief Compliance Officer
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings